Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a retrospective review from the Royal Victoria Hospital in Montreal, among patients with heparin-induced thrombocytopenia, those who had underlying malignancy were found to have a greater risk for thrombotic events when compared to those without malignant disease.

HIT (Heparin-Induced Thrombocytopenia) Complications in Cancer Patients